Wyeth reported a structurally related series of quinazolines as potent inhibitors targeting β-catenin-TCF/LEF-mediated transcription and proliferation in colorectal cancer cell lines and xenograft models [15,34]. The gene discussed is HNF4A; the disease is colorectal cancer.